Our dedicated pediatric hematologists and oncologists provide care for children with all forms of cancer and blood diseases, including leukemia, malignant tumors and lymphomas, as well as sickle cell disease, hemophilia, coagulation abnormalities and platelet disorders. Our participation in the Children's Oncology Group studies makes it possible to provide the most current and advanced treatment regimens to children with any form of cancer, common or rare.
Care of our patients and advances in treating pediatric cancer and blood diseases require a team approach. Our multidisciplinary team of physicians in pediatrics, laboratory medicine, surgery, neurosurgery, orthopedics, pathology, therapeutic radiology and diagnostic radiology work together on a case-by-case basis to treat each child.
Hematology, oncology and stem cell transplantation is unique in its depth of experience and skill in the latest advances in diagnosing and treating childhood cancer and blood disorders. Our infant, child and young adult patients with cancer are offered the best opportunity for accurate diagnosis and the most effective treatment available. In fact, Yale New Haven Children's Hospital is the first and only hospital in Connecticut to offer Chimeric Antigen Receptor (CAR) T-cell therapy. The therapy involves reprogramming the patient's own T-cells to target tumor antigens.
High school student Nicole Graham was diagnosed with leukemia during her junior year and soon found herself in the PICU with life-threatening complications. Her disease is in remission now — she attended her junior prom — and she remembers fondly the care she received at YNHCH, from expert physicians and some very special nurses.
Retinoblastoma is a rare type of eye cancer that usually develops in early childhood, typically before the age of 5. Yale New Haven specialists offer novel treatment options, tailored for each patient.
With MyChart, you can view your test results and doctor's comments from the comfort of your own home.
